Trui Hebbelinck Appointed Chief Human Resources Officer of LivaNova

Xenter, Inc. Appoints 4 Industry Leaders to Board of Directors; Closes $12M Series A

Xenter’s first product, which the company will announce shortly, is a medical device that not only combines the function of multiple existing devices but will also revolutionize the field of interventional medicine by producing valuable Physical Intelligence™ data and enabling advanced Artificial Intelligence solutions, leading to improved patient outcomes while reducing the cost, complexity and invasiveness of cardiac procedures.

Indivumed Partners with Oslo University Hospital to Advance Cancer Research

By scanning high-resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months.

Harold Hill Joins NeuX Technologies as Director of Corporate Accounts

Harold Hill is a retired Special Forces Medic, serving 26 years, and led the medical department for a Special Missions Unit within the United States Special Operations Command

LivaNova PLC  today announced Trui Hebbelinck has been appointed Chief Human Resources Officer for the Company. Hebbelinck will lead global human resources, serve on the Executive Leadership Team and report to Chief Executive Officer Damien McDonald.

“Trui brings incredible expertise to LivaNova and has a history of exceptional results,” said McDonald. “I look forward to working together with Trui to ensure we offer employees a workplace where they can thrive and embrace a culture with a patient-first mindset.”

Hebbelinck’s career spans more than 20 years in healthcare, financial services and energy. She began as an HR manager in a private hospital, after which she joined General Electric followed by Shell. Hebbelinck has driven various talent programs, acquisition integrations and HR transformations, contributing to substantial growth for the companies where she has worked.

“I am eager to return to the healthcare industry and offer my support to the LivaNova team,” said Hebbelinck. “The commitment of LivaNova to improve the lives of patients is evident and compelling. Helping advance this growing company is an opportunity that I am really looking forward to.”

Hebbelinck earned a Master of Science in Psychology from Ghent University in Belgium and a post-graduate degree in Business Management & Administration from the University of Leuven in Belgium.



Subscribe to Medical Device News Magazine

Related Articles